Alnylam hypertension drug meets main goal in mid-stage study

(Reuters) – Alnylam Pharmaceuticals said on Thursday its experimental therapy for hypertension met the main goal in a mid-stage study.

(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)